Diastolic Dysfunction Clinical Trial
Official title:
Effects of Levosimendan on Systolic Deformation and Diastolic Function in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
This is a clinical, randomised, double-blinded study in which patients eligible for aortic valve replacement are enrolled. Patients receive infusion of either levosimendan or placebo 4 hours prior to surgery and until the end of surgery.
Levosimendan or placebo will be infusion for approximately 4 hours prior to aortic valve
replacement in patients with severe hypertrophy of the left ventricle and echocardiographic
signs of diastolic dysfunction. Outcome measures will be obtained at some of the following:
- Approximately 4 hours prior to surgery. Baseline. Start of levosimendan/placebo infusion
- Immediately before surgery
- After induction of anaesthesia and before "knife time" = start of surgery.
- At the end of surgery: Levosimendan infusion will stop.
- Approximately 4 hours after surgery immediately before extubation.
- Approximately 21 hours after surgery
- Approximately 96 hours after surgery (day 4)
- 6 months after surgery
Outcome measures are comprised of invasive measurements, blood samples, transthoracic
echocardiography and transoesophageal echocardiography focusing on measures of systolic and
diastolic function of the heart.
Interim analysis will be conducted after 30 included patients.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Recruiting |
NCT02499601 -
CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Recruiting |
NCT05552521 -
Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
|
||
Recruiting |
NCT05438030 -
Diastolic Function Assessment With Cardiac Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT04128735 -
Diastolic Dysfunction in Morbidly Obese Patients Undergo Bariatric Surgery
|
||
Completed |
NCT00689819 -
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
|
N/A | |
Recruiting |
NCT04149990 -
Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
|
Phase 2 | |
Completed |
NCT03768752 -
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
|
||
Completed |
NCT02932436 -
Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
|
Phase 4 | |
Recruiting |
NCT05847244 -
The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Enrolling by invitation |
NCT04190420 -
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
|
||
Completed |
NCT04114474 -
Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications
|
||
Not yet recruiting |
NCT06131008 -
Diastology-Guided Management of Decompensated Heart Failure
|
N/A | |
Completed |
NCT03110614 -
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD
|
||
Not yet recruiting |
NCT02285309 -
Perioperative Measurements of Diastolic Function in Cardiac Surgery
|
N/A | |
Completed |
NCT01761318 -
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
|
Phase 4 | |
Completed |
NCT00804518 -
Effect of Exercise on Heart Function in Healthy Elderly People
|
N/A | |
Completed |
NCT00907439 -
Study of the Effect of Inhaled Anesthetics on Diastolic Heart Function Using a Doppler-derived Efficiency Index
|
N/A | |
Completed |
NCT01061450 -
Simvastatin and Diastolic Dysfunction
|
Phase 4 |